Lotemax Ophthalmic Gel 0.5% 5g – Steroid Eye Gel for Post-Operative Inflammation & Pain

Prescription Eye Gel for Relief of Inflammation & Pain Following Eye Surgery

Lotemax Ophthalmic Gel 0.5% 5g contains loteprednol etabonate 0.5%, a corticosteroid specially formulated to reduce eye inflammation and pain following ocular surgery. Its non-settling gel formulation provides a consistent dose without the need for vigorous shaking and offers a comfortable application with a pH similar to natural tears. Lotemax should be used only under the supervision of an eye care professional.

Why Choose Lotemax Ophthalmic Gel 0.5% 5g?

✔ Reduces Post-Operative Inflammation – Helps relieve inflammation after eye surgery.

✔ Relieves Eye Pain – Helps reduce post-surgical eye discomfort and irritation.

✔ Consistent Gel Formula – Non-settling gel provides a uniform dose with each application.

✔ Comfortable to Use – Formulated with a pH close to natural tears for enhanced comfort.

✔ Prescription-Only Medicine – Should be used exactly as directed by your ophthalmologist.

Lotemax Ophthalmic Gel 0.5% 5g Key Features:

● Loteprednol Etabonate 0.5% – A topical corticosteroid that helps reduce inflammation in the eye.

● Gel Technology – Delivers a uniform dose without vigorous shaking before use.

● Post-Surgical Eye Care – Commonly prescribed after cataract and other ocular surgeries to manage inflammation and pain.

● Convenient Dosing – Typically used as 1–2 drops in the affected eye(s) four times daily, starting the day after surgery, or as directed by your eye specialist.

✅ Important Information

Lotemax Ophthalmic Gel is a prescription-only corticosteroid. It should not be used for untreated eye infections, and prolonged use may increase intraocular pressure or delay healing. If treatment continues for more than 10 days, your eye doctor may monitor your eye pressure. Do not wear contact lenses unless your doctor advises it.

🛒 Shop online from PharmaCare Qatar and enjoy trusted eye care products with safe, fast delivery across Qatar.